CheckMyRecalls

ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets

Published
8 Jul 2026
Units affected
6432 bottles
Agency
FDA
Country
United States

The hazard

Subpotent Drug

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: lntas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-458-15.

Brand / company
ACCORD HEALTHCARE, INC.
Codes / lots
Lot # D2401522, Exp Date: 06/2026.
Distribution
US Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 8 Jul 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.